GFI #256 compound records
Document compounds from bulk drug substances with BDS list verification and the supporting rationale retained per record.
Veterinary compounding pharmacies answer to the same USP facility standards as human compounding — plus FDA Guidance for Industry #256 when compounding from bulk drug substances. CompliRx keeps both record sets in one place.
Bulk drug substance decisions without documented BDS list verification
VCPR documentation collected ad hoc at prescription intake
Adverse event reports tracked outside any deadline system
Vet-specific records disconnected from facility monitoring and training evidence
Document compounds from bulk drug substances with BDS list verification and the supporting rationale retained per record.
Maintain veterinary practice and prescriber records with VCPR documentation connected to the compounds they support.
Capture adverse events with the FDA 15-day reporting deadline tracked, so nothing depends on a calendar reminder.
Run the same environmental monitoring, cleaning, training, equipment, and CAPA workflows the rest of the facility uses.
The 90-day pilot includes guided onboarding and configuration around how your facility actually operates.